Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 19,800 shares, a growth of 18.6% from the March 31st total of 16,700 shares. Based on an average daily trading volume, of 3,000 shares, the days-to-cover ratio is presently 6.6 days.

Bioasis Technologies Stock Performance

Shares of Bioasis Technologies stock opened at $0.01 on Friday. The stock has a market capitalization of $1.03 million, a price-to-earnings ratio of -0.43 and a beta of 0.48. Bioasis Technologies has a 1-year low of $0.01 and a 1-year high of $0.21. The firm's 50-day moving average price is $0.02 and its two-hundred day moving average price is $0.05.

Bioasis Technologies Company Profile

(Get Rating)

biOasis Technologies, Inc operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier.

Further Reading

• Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
• MarketBeat Week in Review – 4/24 – 4/28
• How to Invest in the Top Grocery Stocks for This Year
• Array Technologies Brings Solar Flare To 2023 Earnings Forecast
• Best Bank Stocks to Invest in Ahead of Rising Interest Rates
• How to Invest in Farmland: 7 Simple Ways

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.